UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.1-11

2020

Volltextzugriff (PDF)

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

Annals of oncology, 2017-11, Vol.28 (11), p.2747-2753

2017

Volltextzugriff (PDF)

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

Annals of oncology, 2020-10, Vol.31 (10), p.1415-1416

2020

Volltextzugriff (PDF)

P255 Breast cancer surgery with ‘pecs block’ technique in the oldest old

Breast (Edinburgh), 2023-04, Vol.68, p.S116-S117

2023

Volltextzugriff (PDF)

Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies

British journal of cancer, 2024-01, Vol.130 (1), p.135-142

2024

Volltextzugriff (PDF)

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin

Annals of oncology, 2022-11, Vol.33 (11), p.1179-1185

2022

Volltextzugriff (PDF)

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Annals of oncology, 2012-09, Vol.23 (9), p.2409-2414

2012

Volltextzugriff (PDF)

Video-endoscopic single-port breast surgery: personal experience

Breast (Edinburgh), 2021-04, Vol.56, p.S76

2021

Volltextzugriff (PDF)

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

Annals of oncology, 2018-07, Vol.29 (7), p.1604-1604

2018

Volltextzugriff (PDF)

Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab

Annals of oncology, 2017-10, Vol.28, p.vi60-vi60

2017

Volltextzugriff (PDF)

Correlation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study

Annals of oncology, 2018-10, Vol.29, p.viii316-viii316

2018

Volltextzugriff (PDF)

Are adverse events (AEs) predictive of nivolumab activity? Data from the Italian expanded access program in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2018-10, Vol.29, p.viii314-viii314

2018

Volltextzugriff (PDF)

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

ESMO open, 2022-12, Vol.7 (6), p.100634, Article 100634

2022

Volltextzugriff (PDF)

CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure

Annals of oncology, 2017-10, Vol.28, p.vi17-vi17

2017

Volltextzugriff (PDF)

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis

European journal of cancer (1990), 2017-02, Vol.72, p.S190-S190

2017

Volltextzugriff (PDF)

Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials

International journal of hepatology (New York), 2018-01, Vol.2018 (2018), p.1-13

2018

Volltextzugriff (PDF)

2603 Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)

European journal of cancer (1990), 2015-09, Vol.51, p.S512-S513

2015

Volltextzugriff (PDF)

Influence of a Spirulina platensis Biomass on the Microflora of Fermented ABT Milks During Storage (R1)

Journal of dairy science, 2002-05, Vol.85 (5), p.1031-1038

2002

Volltextzugriff (PDF)

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]

ESMO open, 2021-06, Vol.6 (3), p.100137-100137, Article 100137

2021

Volltextzugriff (PDF)

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)

Targeted oncology, 2015-06, Vol.10 (2), p.277-286

2015

Volltextzugriff (PDF)

Fourier transform infrared spectroscopy as a suitable technique in the study of the materials used in waterproofing of archaeological amphorae

Analytica chimica acta, 2007-08, Vol.598 (1), p.119-127

2007

Volltextzugriff (PDF)

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Journal of hepatology, 2017-08, Vol.67 (2), p.370-398

2017

Volltextzugriff (PDF)

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C

International Journal of Hepatology, 2016-01, Vol.2016 (2016), p.1-8

2016

Volltextzugriff (PDF)

Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management

International Journal of Hepatology, 2015-01, Vol.2015 (2015), p.1-6

2015

Volltextzugriff (PDF)

1599P Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study

Annals of oncology, 2023-10, Vol.34, p.S888-S888

2023

Volltextzugriff (PDF)

1 – 25 von 2.629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.111)
Mit Volltextzugriff
(2.217)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.164)
Life Sciences & Biomedicine
(952)
Humans
(699)
Male
(358)
Female
(349)
Gastroenterology & Hepatology
(326)
Middle Aged
(283)
Adult
(251)
Oncology
(208)
Gastroenterology And Hepatology
(188)
Aged
(170)
Physical Sciences
(166)
Antiviral Agents - Therapeutic Use
(165)
Treatment Outcome
(162)
Infectious Diseases
(150)
Biological And Medical Sciences
(149)
Medical Sciences
(137)
Patients
(136)
Hepatitis
(134)
Immunotherapy
(126)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(441)
Journal Of Clinical Oncology
(73)
Annals Of Oncology
(56)
Hepatology
(45)
Gastroenterology
(44)
Journal Of Viral Hepatitis
(36)
Gastroenterología Y Hepatología
(33)
Alimentary Pharmacology & Therapeutics
(32)
Physical Review. C, Nuclear Physics
(30)
Sfera Politicii
(30)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

P255 Breast cancer surgery with ‘pecs block’ technique in the oldest old

Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Video-endoscopic single-port breast surgery: personal experience

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab

Correlation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study

Are adverse events (AEs) predictive of nivolumab activity? Data from the Italian expanded access program in metastatic renal cell carcinoma (mRCC)

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis

Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials

2603 Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)

Influence of a Spirulina platensis Biomass on the Microflora of Fermented ABT Milks During Storage (R1)

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)

Fourier transform infrared spectroscopy as a suitable technique in the study of the materials used in waterproofing of archaeological amphorae

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C

Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management

1599P Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study

Suchergebnisse filtern